# Dipushenhe

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dipushenhe

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Latest round: Angel (Feb 19, 2025)
- Investors on record: 3

## About

Founded in 2024 and based in Shanghai, China, Dipushenhe is a pharmaceutical research and development company that focuses on the development of translational medicine and synthetic biology technologies. In February 2025, the firm raised angel funding from new investors Houxue Capital, Lihe Finance, and Xiaomiao Langcheng Capital. Jiajia Dong, the founder of the company, once worked in K. Barry Sharpless team and the Institute of Organic Chemistry of the Chinese Academy of Sciences.

The company's main products are modular click compound libraries and lead compounds. Lead compounds can be used to produce large molecule and small molecule drugs, as well as cosmetic products.

The company’s revenue is generated by providing modular click compound libraries.

The company will use the angel funding for the construction of click chemistry automated laboratories, as well as the establishment of azide compound libraries and AI data bases.

## Funding rounds

- Angel, Feb 19, 2025 — Leaguer Financial, Xiaomiao Langcheng Capital, Houxue Capital

## Investors

- Leaguer Financial — Angel
- Xiaomiao Langcheng Capital (https://capitalatlas.ai/funds/xiaomiao-langcheng-capital) — Angel
- Houxue Capital (https://capitalatlas.ai/funds/houxue-capital) — Angel